Pharmaceutical Products

Product Name: Ostarine
Synonyms: MK-2866 (GTx-024)
CAS: 841205-47-8
MF: C19H14F3N3O3
MW: 389.3279696
Mp: 70-74 °C (158-165 °F)
Bp: 632.261 °C at 760 mmHg
Storage: Store in a cool, dry place and keep away from direct strong light.
Appearance : white powder

Description:
Ostarine is an orally active nonsteroidal SARM developed by GTx, Inc. A 12-week double-blind, placebo-controlled phase II clinical trial on 120 healthy elderly men (60+ years old) and postmenopausal women showed that Ostarine significantly increased lean body mass, improved physical function, and improved insulin sensitivity.
In the fitness industry users typically take Ostarine during bulking and recomposition phases. During bulking phases some users report 7lb increases in lean body mass in just 8 weeks and users report decreased fat mass and slight increases in muscle and strength.
A compound that offers both fat loss, muscle gain, and strength gain benefits sounds extremely appealing to athletes looking to take their performance to the next-level. However, Ostarine does have two significant side effects – HPG axis suppression and elevated estradiol levels; both of which users report can be remedied with a 3-week PCT. If you do decide to take Ostarine, it’s extremely important that you follow the directions on the label and perform the PCT to mitigate further, more serious side effects.

Application:
Ostarine is a potent and tissue-selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis. These patent products for research purposes only use. Ostarine (GTx-024, MK-2866, Enobosarm, S-22) is an orally bioavailable nonsteroidal selective androgen receptor modulator. Therefore, ostarine can be used for treatment of conditions such as muscle wasting and osteoporosis.